Consolidated financial report according to BFSC standards as at 31 December 2023
Русский
Sofia, Bulgaria, February 27, 2024 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that in pursuance of a decision of the General meeting of Holders of Warrants (GMHW) held on January 26, 2024 and decision of the Board of Directors of SOPHARMA AD from a meeting held on January 26, 2024 and based on art. 195 and art. 196 of the Commercial Law (CL), art. 113, para. 2, item 2 of Law on public offering of securities (LPOS) and art.
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 as of 20 February 2024 re exercising warrants - correction